New hope for rare kidney disease: major trial tests potential treatment
Disease control
Recruiting now
This study is testing if an experimental drug called DMX-200, taken alongside a standard blood pressure medication, can help control a rare and serious kidney disease called FSGS. About 286 patients, including teens and adults, will take either the new drug or a placebo for two y…
Phase: PHASE3 • Sponsor: Dimerix Bioscience Pty Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC